Showing results (21-30 of 28) with videos related to
Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 28 results.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|April 10, 2020
Prediction for Progression Risk in Patients With COVID-19 Pneumonia: The CALL ScoreDong Ji, Dawei Zhang, Jing Xu, et al.Iscience|May 11, 2026
Age modulates estradiol's dual role in hepatocellular carcinoma recurrence after ablation: A prospective observational studyXudong Gao, Jingfeng Bi, Shuwen Yang, et al.BMC Cancer|November 10, 2017
A novel chemotherapeutic sensitivity-testing system based on collagen gel droplet embedded 3D-culture methods for hepatocellular carcinomaJun Hou, Zhixian Hong, Fan Feng, et al.Nanoscale Research Letters|April 9, 2015
Investigation of GaInAs strain reducing layer combined with InAs quantum dots embedded in Ga(In)As subcell of triple junction GaInP/Ga(In)As/Ge solar cellSenlin Li, Jingfeng Bi, Mingyang Li, et al.Frontiers in Neuroscience|May 8, 2023
Microstructural and functional impairment of the basal ganglia in Wilson's disease: a multimodal neuroimaging studyDongning Su, Zhijin Zhang, Zhe Zhang, et al.Journal of Hepatology|August 19, 2022
Entecavir plus Biejia-Ruangan compound reduces the risk of hepatocellular carcinoma in Chinese patients with chronic hepatitis BDong Ji, Yan Chen, Jingfeng Bi, et al.The Journal of Infectious Diseases|May 22, 2020
Synergistic Effect of Biejia-Ruangan on Fibrosis Regression in Patients With Chronic Hepatitis B Treated With Entecavir: A Multicenter, Randomized, Double-Blind, Placebo-Controlled TrialGuanghua Rong, Yongping Chen, Zujiang Yu, et al.Frontiers in Medicine|March 25, 2026
Ishak stage 6 fibrosis is more likely to regress than stage 5 in CHB patients undergoing entecavir therapyMengjie Li, Xiaogang Hao, Yuanyuan Li, et al.Pageof 3